Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

Could C3.ai Stock Impress Wall Street With a 156% Return This Year?

C3.ai's income statement is getting uglier as the business grows and Wall Street is divided on AI stock's prospects in 2022. A recent short-seller's report isn't helping matters.

SoFi Stock Is In a Bear Market, but So What? 

SOFI stock has been pummeled, along with the rest of its growth-stock peers. Here's why I'm not completely giving up on it though.

Why You’d Be Crazy to Short Digital World Acquisition Stock

Under most circumstances, I'd say DWAC stock presents a huge red flag. But the level of support for its shares goes beyond what is normal.

Hedge Funds are Selling Paysafe at the Wrong Time

Paysafe is at an inflection point as Hedge Funds lose faith. The stock could retrieve its previous losses because of the simple fact that it got mistreated by investors towards the end of last year.

Wait For a $5 Entry Point to Buy Solid Power

Solid Power could end up being a solid renewable energy sector investment. However, as a SPAC, wait for SLDP stock to fall further before buying.

7 Stocks With Earnings Reports Next Week

Over the next week, we'll get fourth-quarter earnings reports from several leading companies. Here are the seven results to keep an eye on.

Grab Holdings: Bag of Assets in Southeast Asia

Grab's purchase of grocer Jaya Foods gives it heft and a financial ally it needs as it resumes its growth trajectory.

Is Matterport Stock a Buy? Not Right Now.

Matterport is losing twice as much money as it takes in, but its data on spaces has real potential, according to MTTR stock bulls.

The Time for QuantumScape to Strike is Right Now

While soaring consumer inflation presents an opportunity for QS stock, QuantumScape must deliver a viable product soon.

Polestar Should Be a Hit When its Reverse Merger with Gores Guggenheim Closes

GGPI stock is worth at least 59% more and could hit $19 per share once the reverse merger with Polestar goes through in 2022.

The Xilinx Deal Will Accelerate Growth in Advanced Micro Devices

AMD stock rose overnight after it increased its addressable market and gained new strength against Intel's designs through buying Xilinx.

Aggressive Investors Could Like SoFi Stock While Its ETFs Offer Alternative

SoFi Technologies continues to add new products such as ETFs for its 2.9 million members. That’s very good news if you own SOFI stock.

How The Activision Blizzard Purchase Helps Microsoft Stock

Microsoft and MSFT stock will benefit from the Activision Blizzard deal, as multiple catalysts will help this purchase be very worthwhile.

StoneCo May Have Potential, But It Comes with Macroeconomic Risks

STNE stock is a risky fintech name. While StoneCo does provide revenue growth, the business is also subject to operating weakness.

Use Weakness as Opportunity with Affirm Holdings Stock

In Q2 2022, the company more than doubled its gross merchandise volume (GMV) year over year. In fact, that number was up 115% to $4.5 billion.

Fast-Moving Upstart Stock Requires Patience After Earnings Pop

UPST stock has left very little room for easy entry. Investors must be cautious and buy it on less obvious days than those with a big pop.

Don’t Get Burnt with Toast Stock as Profitability Remains Elusive

TOST stock ran high post-IPO, but then dropped fast. Expect continued volatility as Toast struggles to find its financial footing.

Don’t Expect Skillz to Rise Until It Can Show Profits

Skillz will release Q4 earnings on Feb. 23, but don't expect SKLZ stock to move much higher until the company gets on track to make money.

Novavax Just Can’t Get it Together

Patient investors should wait for NVAX stock to hit another low or for the FDA to approve its Covid-19 vaccine before investing.